Moan, J., Porojnicu, A. C., Dahlback, A., et al.: Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. Proc. Natl. Acad. Sci. USA, 2008, 105, 668–673.

Dahlback A. , 'Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure ' (2008 ) 105 Proc. Natl. Acad. Sci. USA : 668 -673 .

Dahlback A. Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure Proc. Natl. Acad. Sci. USA 2008 105 668 673 )| false
• Search Google Scholar

Holick, M. F., Chen, T. C.: Vitamin D deficiency: a worldwide problem with health consequences. Am. J. Clin. Nutr., 2008, 87, 1080S–1086S.

Chen T. C. , 'Vitamin D deficiency: a worldwide problem with health consequences ' (2008 ) 87 Am. J. Clin. Nutr. : 1080S -1086S .

Chen T. C. Vitamin D deficiency: a worldwide problem with health consequences Am. J. Clin. Nutr. 2008 87 1080S 1086S )| false
• Search Google Scholar

Holick, M. F., Chen, T. C., Lu, Z., et al.: Vitamin D and skin physiology: a D-lightful story. J. Bone Miner. Res., 2007, 22 (Suppl. 2), V28–33.

Lu Z. , 'Vitamin D and skin physiology: a D-lightful story ' (2007 ) 22 J. Bone Miner. Res. : V28 -33 .

Lu Z. Vitamin D and skin physiology: a D-lightful story J. Bone Miner. Res. 2007 22 V28 33 )| false
• Search Google Scholar

Holick, M. F.: Vitamin D deficiency. N. Engl. J. Med., 2007, 357, 266–281.

Holick M. F. , 'Vitamin D deficiency ' (2007 ) 357 N. Engl. J. Med. : 266 -281 .

Holick M. F. Vitamin D deficiency N. Engl. J. Med. 2007 357 266 281 )| false
• Search Google Scholar

Holick, M. F.: Vitamin D: a D-lightful health perspective. Nutr. Rev., 2008, 66 (10 Suppl. 2), S182–194.

Holick M. F. , 'Vitamin D: a D-lightful health perspective ' (2008 ) 66 Nutr. Rev. : S182 -194 .

Holick M. F. Vitamin D: a D-lightful health perspective Nutr. Rev. 2008 66 S182 194 )| false
• Search Google Scholar

Lugtenburg, J., Havinga, E.: Studies on vitamin D and related compounds XX. The conformation of tachysterol; N. O. E. and 220 MHz N. M. R. Tetrahedron Lett., 1969, 28, 2391–2394.

Havinga E. , 'Studies on vitamin D and related compounds XX. The conformation of tachysterol; N. O. E. and 220 MHz N. M. R ' (1969 ) 28 Tetrahedron Lett. : 2391 -2394 .

Havinga E. Studies on vitamin D and related compounds XX. The conformation of tachysterol; N. O. E. and 220 MHz N. M. R Tetrahedron Lett. 1969 28 2391 2394 )| false
• Search Google Scholar

Clemens, T. L., Adams, J. S., Henderson, S. L., et al.: Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet, 1982, 319, 74–76.

Henderson S. L. , 'Increased skin pigment reduces the capacity of skin to synthesise vitamin D3 ' (1982 ) 319 Lancet : 74 -76 .

Henderson S. L. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3 Lancet 1982 319 74 76 )| false
• Search Google Scholar

Need, A. G., Morris, H. A., Horowitz M., et al.: Effects of skin thickness, age, body fat, and sunlight on serum 25-hydroxyvita-min D. Am. J. Clin. Nutr., 1993, 58, 882–885.

Horowitz M. , 'Effects of skin thickness, age, body fat, and sunlight on serum 25-hydroxyvita-min D ' (1993 ) 58 Am. J. Clin. Nutr. : 882 -885 .

Horowitz M. Effects of skin thickness, age, body fat, and sunlight on serum 25-hydroxyvita-min D Am. J. Clin. Nutr. 1993 58 882 885 )| false
• Search Google Scholar

Zajkas, G., Biro, L., Greiner, E., et al.: Dietary survey in Hungary, 2003–2004. Micronutrients: vitamins. [Táplálkozási vizsgálat Magyarországon, 2003–2004. Mikrotápanyagok: vitaminok.] Orv. Hetil., 2007, 148, 1593–1600. [Hungarian]

Greiner E. , 'Dietary survey in Hungary, 2003–2004. Micronutrients: vitamins. [Táplálkozási vizsgálat Magyarországon, 2003–2004. Mikrotápanyagok: vitaminok.] ' (2007 ) 148 Orv. Hetil. : 1593 -1600 .

Greiner E. Dietary survey in Hungary, 2003–2004. Micronutrients: vitamins. [Táplálkozási vizsgálat Magyarországon, 2003–2004. Mikrotápanyagok: vitaminok.] Orv. Hetil. 2007 148 1593 1600 )| false
• Search Google Scholar

Heaney, R. P.: Vitamin D endocrine physiology. J. Bone Miner. Res., 2007, 22 (Suppl 2), V25–27.

Heaney R. P. , 'Vitamin D endocrine physiology ' (2007 ) 22 J. Bone Miner. Res. : V25 -27 .

Heaney R. P. Vitamin D endocrine physiology J. Bone Miner. Res. 2007 22 V25 27 )| false
• Search Google Scholar

DeLuca, H. F.: Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr., 2004, 80 (6 Suppl), 1689S–1696S.

DeLuca H. F. , 'Overview of general physiologic features and functions of vitamin D ' (2004 ) 80 Am. J. Clin. Nutr. : 1689S -1696S .

DeLuca H. F. Overview of general physiologic features and functions of vitamin D Am. J. Clin. Nutr. 2004 80 1689S 1696S )| false
• Search Google Scholar

Tangpricha, V., Flanagan, J. N., Whitlatch, L. W., et al.: 25-hy-droxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet, 2001, 357, 1673–1674.

Whitlatch L. W. , '25-hy-droxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue ' (2001 ) 357 Lancet : 1673 -1674 .

Whitlatch L. W. 25-hy-droxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue Lancet 2001 357 1673 1674 )| false
• Search Google Scholar

Somjen, D., Weisman, Y., Kohen F., et al.: 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation, 2005, 111, 1666–1671.

Kohen F. , '25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds ' (2005 ) 111 Circulation : 1666 -1671 .

Kohen F. 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds Circulation 2005 111 1666 1671 )| false
• Search Google Scholar

Eelen, G., Verlinden L., van Camp, M., et al.: The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes. J. Bone Miner. Res., 2004, 19, 133–146.

Camp M. , 'The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes ' (2004 ) 19 J. Bone Miner. Res. : 133 -146 .

Camp M. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes J. Bone Miner. Res. 2004 19 133 146 )| false
• Search Google Scholar

Ellison, T. I., Dowd, D. R., MacDonald, P. N.: Calmodulin-dependent kinase IV stimulates vitamin D receptor-mediated transcription. Mol. Endocrinol., 2005, 19, 2309–2319.

MacDonald P. N. , 'Calmodulin-dependent kinase IV stimulates vitamin D receptor-mediated transcription ' (2005 ) 19 Mol. Endocrinol. : 2309 -2319 .

MacDonald P. N. Calmodulin-dependent kinase IV stimulates vitamin D receptor-mediated transcription Mol. Endocrinol. 2005 19 2309 2319 )| false
• Search Google Scholar

Kim, S., Shevde, N. K., Pike, J. W.: 1,25-dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J. Bone Miner. Res., 2005, 20, 305–317.

Pike J. W. , '1,25-dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts ' (2005 ) 20 J. Bone Miner. Res. : 305 -317 .

Pike J. W. 1,25-dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts J. Bone Miner. Res. 2005 20 305 317 )| false
• Search Google Scholar

Armas, L. A., Hollis, B. W., Heaney, R. P.: Vitamin D2 is much less effective than vitamin D3 in humans. J. Clin. Endocrinol. Metab., 2004, 89, 5387–5391.

Heaney R. P. , 'Vitamin D2 is much less effective than vitamin D3 in humans ' (2004 ) 89 J. Clin. Endocrinol. Metab. : 5387 -5391 .

Heaney R. P. Vitamin D2 is much less effective than vitamin D3 in humans J. Clin. Endocrinol. Metab. 2004 89 5387 5391 )| false
• Search Google Scholar

Trang, H. M., Cole, D. E., Rubin, L. A.: Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am. J. Clin. Nutr., 1998, 68, 854–858.

Rubin L. A. , 'Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2 ' (1998 ) 68 Am. J. Clin. Nutr. : 854 -858 .

Rubin L. A. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2 Am. J. Clin. Nutr. 1998 68 854 858 )| false
• Search Google Scholar

Cranney, A., Weiler, H. A., O’Donnell S.: Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am. J. Clin. Nutr., 2008, 88, 513S–519S.

O’Donnell S. , 'Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health ' (2008 ) 88 Am. J. Clin. Nutr. : 513S -519S .

O’Donnell S. Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health Am. J. Clin. Nutr. 2008 88 513S 519S )| false
• Search Google Scholar

Chandra, P., Binongo, J. N., Ziegler, T. R., et al.: Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr. Pract., 2008, 14, 10–17.

Ziegler T. R. , 'Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study ' (2008 ) 14 Endocr. Pract. : 10 -17 .

Ziegler T. R. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study Endocr. Pract. 2008 14 10 17 )| false
• Search Google Scholar

Feldman, D., Pike, J. W., Adams, J. S.: Vitamin D. 3rd ed. Academic Press, Amsterdam, Boston, 2011, 1042.

Adams J. S. , '', in Vitamin D , (2011 ) -.

Adams J. S. Vitamin D 2011 )| false

Nazarian, S., St Peter, J. V., Boston, R. C., et al.: Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose. Transl. Res., 2011, 158, 276–281.

Boston R. C. , 'Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose ' (2011 ) 158 Transl. Res. : 276 -281 .

Boston R. C. Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose Transl. Res. 2011 158 276 281 )| false
• Search Google Scholar

Barengolts, E.: Vitamin D role and use in prediabetes. Endocr. Pract., 2010, 16, 476–485.

Barengolts E. , 'Vitamin D role and use in prediabetes ' (2010 ) 16 Endocr. Pract. : 476 -485 .

Barengolts E. Vitamin D role and use in prediabetes Endocr. Pract. 2010 16 476 485 )| false
• Search Google Scholar

Brouwer, D. A., van Beek, J., Ferwerda, H., et al.: Rat adipose tissue rapidly accumulates and slowly releases an orally-administered high vitamin D dose. Br. J. Nutr., 1998, 79, 527–532.

Ferwerda H. , 'Rat adipose tissue rapidly accumulates and slowly releases an orally-administered high vitamin D dose ' (1998 ) 79 Br. J. Nutr. : 527 -532 .

Ferwerda H. Rat adipose tissue rapidly accumulates and slowly releases an orally-administered high vitamin D dose Br. J. Nutr. 1998 79 527 532 )| false
• Search Google Scholar

Montgomery, J. L., Parrish, F. C., Jr. Beitz, D. C., et al.: The use of vitamin D3 to improve beef tenderness. J. Anim. Sci., 2000, 78, 2615–2621.

Beitz D. C. , 'The use of vitamin D3 to improve beef tenderness ' (2000 ) 78 J. Anim. Sci. : 2615 -2621 .

Beitz D. C. The use of vitamin D3 to improve beef tenderness J. Anim. Sci. 2000 78 2615 2621 )| false
• Search Google Scholar

Gomme, P. T., Bertolini, J.: Therapeutic potential of vitamin D-binding protein. Trends Biotechnol., 2004, 22, 340–345.

Bertolini J. , 'Therapeutic potential of vitamin D-binding protein ' (2004 ) 22 Trends Biotechnol. : 340 -345 .

Bertolini J. Therapeutic potential of vitamin D-binding protein Trends Biotechnol. 2004 22 340 345 )| false
• Search Google Scholar

Bouillon, R., Okamura, W. H., Norman, A. W.: Structure-function relationships in the vitamin D endocrine system. Endocrine Reviews, 1995, 16, 200–257.

Norman A. W. , 'Structure-function relationships in the vitamin D endocrine system ' (1995 ) 16 Endocrine Reviews : 200 -257 .

Norman A. W. Structure-function relationships in the vitamin D endocrine system Endocrine Reviews 1995 16 200 257 )| false
• Search Google Scholar

Moestrup, S. K., Verroust, P. J.: Megalin- and cubilin-mediated endocytosis of protein-bound vitamins, lipids, and hormones in polarized epithelia. Annu. Rev. Nutr., 2001, 21, 407–428.

Verroust P. J. , 'Megalin- and cubilin-mediated endocytosis of protein-bound vitamins, lipids, and hormones in polarized epithelia ' (2001 ) 21 Annu. Rev. Nutr. : 407 -428 .

Verroust P. J. Megalin- and cubilin-mediated endocytosis of protein-bound vitamins, lipids, and hormones in polarized epithelia Annu. Rev. Nutr. 2001 21 407 428 )| false
• Search Google Scholar

Willnow, T. E., Nykjaer, A.: Cellular uptake of steroid carrier proteins – mechanisms and implications. Mol. Cell. Endocrinol., 2010, 316, 93–102.

Nykjaer A. , 'Cellular uptake of steroid carrier proteins – mechanisms and implications ' (2010 ) 316 Mol. Cell. Endocrinol. : 93 -102 .

Nykjaer A. Cellular uptake of steroid carrier proteins – mechanisms and implications Mol. Cell. Endocrinol. 2010 316 93 102 )| false
• Search Google Scholar

Norman, A. W.: From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am. J. Clin. Nutr., 2008, 88, 491S–499S.

Norman A. W. , 'From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health ' (2008 ) 88 Am. J. Clin. Nutr. : 491S -499S .

Norman A. W. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health Am. J. Clin. Nutr. 2008 88 491S 499S )| false
• Search Google Scholar

Vieth, R.: Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am. J. Clin. Nutr., 1999, 69, 842–856.

Vieth R. , 'Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety ' (1999 ) 69 Am. J. Clin. Nutr. : 842 -856 .

Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety Am. J. Clin. Nutr. 1999 69 842 856 )| false
• Search Google Scholar

Pettifor, J. M., Bikle, D. D., Cavaleros, M., et al.: Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity. Ann. Intern. Med., 1995, 122, 511–513.

Cavaleros M. , 'Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity ' (1995 ) 122 Ann. Intern. Med. : 511 -513 .

Cavaleros M. Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity Ann. Intern. Med. 1995 122 511 513 )| false
• Search Google Scholar

Amir, E., Simmons, C. E., Freedman, O. C., et al.: A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases. Cancer, 2010, 116, 284–291.

Freedman O. C. , 'A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases ' (2010 ) 116 Cancer : 284 -291 .

Freedman O. C. A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases Cancer 2010 116 284 291 )| false
• Search Google Scholar

Blank, S., Scanlon, K. S., Sinks, T. H., et al.: An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy. Am. J. Public Health, 1995, 85, 656–659.

Sinks T. H. , 'An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy ' (1995 ) 85 Am. J. Public Health : 656 -659 .

Sinks T. H. An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy Am. J. Public Health 1995 85 656 659 )| false
• Search Google Scholar

Vieth, R., Chan, P. C., MacFarlane, G. D.: Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am. J. Clin. Nutr., 2001, 73, 288–294.

MacFarlane G. D. , 'Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level ' (2001 ) 73 Am. J. Clin. Nutr. : 288 -294 .

MacFarlane G. D. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level Am. J. Clin. Nutr. 2001 73 288 294 )| false
• Search Google Scholar

Aloia, J. F., Patel, M., Dimaano, R., et al.: Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am. J. Clin. Nutr., 2008, 87, 1952–1958.

Dimaano R. , 'Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration ' (2008 ) 87 Am. J. Clin. Nutr. : 1952 -1958 .

Dimaano R. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration Am. J. Clin. Nutr. 2008 87 1952 1958 )| false
• Search Google Scholar

Hathcock, J. N., Shao, A., Vieth, R., et al.: Risk assessment for vitamin D. Am. J. Clin. Nutr., 2007, 85, 6–18.

Vieth R. , 'Risk assessment for vitamin D ' (2007 ) 85 Am. J. Clin. Nutr. : 6 -18 .

Vieth R. Risk assessment for vitamin D Am. J. Clin. Nutr. 2007 85 6 18 )| false
• Search Google Scholar

Burton, J. M., Kimball, S., Vieth, R., et al.: A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology, 2010, 74, 1852–1859.

Vieth R. , 'A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis ' (2010 ) 74 Neurology : 1852 -1859 .

Vieth R. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis Neurology 2010 74 1852 1859 )| false
• Search Google Scholar

Heaney, R. P., Davies, K. M., Chen., T. C., et al.: Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr., 2003, 77, 204–210.

Chen. T. C. , 'Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol ' (2003 ) 77 Am. J. Clin. Nutr. : 204 -210 .

Chen. T. C. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol Am. J. Clin. Nutr. 2003 77 204 210 )| false
• Search Google Scholar

Kimball, S. M., Ursell, M. R., O’Connor, P. , et al.: Safety of vitamin D3 in adults with multiple sclerosis. Am. J. Clin. Nutr., 2007, 86, 645–651.

O’Connor P. , 'Safety of vitamin D3 in adults with multiple sclerosis ' (2007 ) 86 Am. J. Clin. Nutr. : 645 -651 .

O’Connor P. Safety of vitamin D3 in adults with multiple sclerosis Am. J. Clin. Nutr. 2007 86 645 651 )| false
• Search Google Scholar

Goodman, L. S., Brunton, L. L., Chabner, B., et al.: Goodman & Gilman’s pharmacological basis of therapeutics. McGraw-Hill, New York, 2011, p. 2084.

Chabner B. , '', in Goodman & Gilman’s pharmacological basis of therapeutics , (2011 ) -.

Chabner B. Goodman & Gilman’s pharmacological basis of therapeutics 2011 )| false

Vieth, R., Kimball, S., Hu, A., et al.: Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr. J., 2004, 3, 8.

Hu A. , 'Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients ' (2004 ) 3 Nutr. J. : 8 -.

Hu A. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients Nutr. J. 2004 3 8 )| false
• Search Google Scholar

Sakai, Y., Kishimoto, J., Demay, M. B.: Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice. J. Clin. Invest., 2001, 107, 961–966.

Demay M. B. , 'Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice ' (2001 ) 107 J. Clin. Invest. : 961 -966 .

Demay M. B. Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice J. Clin. Invest. 2001 107 961 966 )| false
• Search Google Scholar

Xie, Z., Komuves, L., Yu, Q. C., et al.: Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. J. Invest. Dermatol., 2002, 118, 11–16.

Yu Q. C. , 'Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth ' (2002 ) 118 J. Invest. Dermatol. : 11 -16 .

Yu Q. C. Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth J. Invest. Dermatol. 2002 118 11 16 )| false
• Search Google Scholar

Li, Y. C., Pirro, A. E., Amling, M., et al.: Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA, 1997, 94, 9831–9835.

Amling M. , 'Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia ' (1997 ) 94 Proc. Natl. Acad. Sci. USA : 9831 -9835 .

Amling M. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia Proc. Natl. Acad. Sci. USA 1997 94 9831 9835 )| false
• Search Google Scholar

Krafka, J.: A simple treatment of psoriasis. J. Lab. Clin. Med., 1936, 21, 1147–1148.

Krafka J. , 'A simple treatment of psoriasis ' (1936 ) 21 J. Lab. Clin. Med. : 1147 -1148 .

Krafka J. A simple treatment of psoriasis J. Lab. Clin. Med. 1936 21 1147 1148 )| false
• Search Google Scholar

Smith, E. L., Walworth, N. C., Holick, M. F.: Effect of 1-alpha, 25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J. Invest. Dermatol., 1986, 86, 709–714.

Holick M. F. , 'Effect of 1-alpha, 25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions ' (1986 ) 86 J. Invest. Dermatol. : 709 -714 .

Holick M. F. Effect of 1-alpha, 25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions J. Invest. Dermatol. 1986 86 709 714 )| false
• Search Google Scholar

Hosomi, J., Hosoi, J., Abe, E., et al.: Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3. Endocrinology, 1983, 113, 1950–1957.

Abe E. , 'Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3 ' (1983 ) 113 Endocrinology : 1950 -1957 .

Abe E. Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3 Endocrinology 1983 113 1950 1957 )| false
• Search Google Scholar

Gniadecki, R., Serup, J.: Stimulation of epidermal proliferation in mice with 1 alpha, 25-dihydroxyvitamin D3 and receptor-active 20-EPI analogues of 1 alpha, 25-dihydroxyvitamin D3. Bio-chem. Pharmacol., 1995, 49, 621–624.

Serup J. , 'Stimulation of epidermal proliferation in mice with 1 alpha, 25-dihydroxyvitamin D3 and receptor-active 20-EPI analogues of 1 alpha, 25-dihydroxyvitamin D3 ' (1995 ) 49 Bio-chem. Pharmacol. : 621 -624 .

Serup J. Stimulation of epidermal proliferation in mice with 1 alpha, 25-dihydroxyvitamin D3 and receptor-active 20-EPI analogues of 1 alpha, 25-dihydroxyvitamin D3 Bio-chem. Pharmacol. 1995 49 621 624 )| false
• Search Google Scholar

Rigby, W. F.: The immunobiology of vitamin D. Immunol. Today, 1988, 9, 54–58.

Rigby W. F. , 'The immunobiology of vitamin D ' (1988 ) 9 Immunol. Today : 54 -58 .

Rigby W. F. The immunobiology of vitamin D Immunol. Today 1988 9 54 58 )| false
• Search Google Scholar

Perez, A., Chen, T. C., Turner, A., et al.: Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis. Br. J. Dermatol., 1996, 134, 238–246.

Turner A. , 'Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis ' (1996 ) 134 Br. J. Dermatol. : 238 -246 .

Turner A. Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis Br. J. Dermatol. 1996 134 238 246 )| false
• Search Google Scholar

Kragballe, K., Beck, H. I., Sogaard, H.: Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study. Br. J. Dermatol., 1988, 119, 223–230.

Sogaard H. , 'Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study ' (1988 ) 119 Br. J. Dermatol. : 223 -230 .

Sogaard H. Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study Br. J. Dermatol. 1988 119 223 230 )| false
• Search Google Scholar

Van de Kerkhof, P. C., van Bokhoven, M., Zultak, M., et al.: A double-blind study of topical 1 alpha,25-dihydroxyvitamin D3 in psoriasis. Br. J. Dermatol., 1989, 120, 661–664.

Zultak M. , 'A double-blind study of topical 1 alpha,25-dihydroxyvitamin D3 in psoriasis ' (1989 ) 120 Br. J. Dermatol. : 661 -664 .

Zultak M. A double-blind study of topical 1 alpha,25-dihydroxyvitamin D3 in psoriasis Br. J. Dermatol. 1989 120 661 664 )| false
• Search Google Scholar

Barker, J. N., Ashton, R. E., Marks, R., et al.: Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator. Br. J. Dermatol., 1999, 141, 274–278.

Marks R. , 'Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator ' (1999 ) 141 Br. J. Dermatol. : 274 -278 .

Marks R. Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator Br. J. Dermatol. 1999 141 274 278 )| false
• Search Google Scholar

Durakovic, C., Malabanan, A., Holick, M. F.: Rationale for use and clinical responsiveness of hexafuoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study. Br. J. Dermatol., 2001, 144, 500–506.

Holick M. F. , 'Rationale for use and clinical responsiveness of hexafuoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study ' (2001 ) 144 Br. J. Dermatol. : 500 -506 .

Holick M. F. Rationale for use and clinical responsiveness of hexafuoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study Br. J. Dermatol. 2001 144 500 506 )| false
• Search Google Scholar

Miyachi, Y., Ohkawara, A., Ohkido, M., et al.: Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris. Eur. J. Dermatol., 2002, 12, 463–468.

Ohkido M. , 'Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris ' (2002 ) 12 Eur. J. Dermatol. : 463 -468 .

Ohkido M. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris Eur. J. Dermatol. 2002 12 463 468 )| false
• Search Google Scholar

Van de Kerkhof, P. C., Berth-Jones, J., Griffiths, C. E., et al.: Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis. Br. J. Dermatol., 2002, 146, 414–422.

Griffiths C. E. , 'Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis ' (2002 ) 146 Br. J. Dermatol. : 414 -422 .

Griffiths C. E. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis Br. J. Dermatol. 2002 146 414 422 )| false
• Search Google Scholar

Armstrong, B. K., Kricker, A.: The epidemiology of UV induced skin cancer. J. Photochem. Photobiol. B., 2001, 63, 8–18.

Kricker A. , 'The epidemiology of UV induced skin cancer ' (2001 ) 63 J. Photochem. Photobiol. B. : 8 -18 .

Kricker A. The epidemiology of UV induced skin cancer J. Photochem. Photobiol. B. 2001 63 8 18 )| false
• Search Google Scholar

Corona, R., Dogliotti, E., D’Errico, M., et al.: Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch. Dermatol., 2001, 137, 1162–1168.

D’Errico M. , 'Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life ' (2001 ) 137 Arch. Dermatol. : 1162 -1168 .

D’Errico M. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life Arch. Dermatol. 2001 137 1162 1168 )| false
• Search Google Scholar

Green, A., Williams, G., Neale, R., et al.: Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet, 1999, 354, 723–729.

Neale R. , 'Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial ' (1999 ) 354 Lancet : 723 -729 .

Neale R. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial Lancet 1999 354 723 729 )| false
• Search Google Scholar

Tang, J. Y., Parimi, N., Wu, A., et al.: Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men. Cancer Causes Control, 2010, 21, 387–391.

Wu A. , 'Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men ' (2010 ) 21 Cancer Causes Control : 387 -391 .

Wu A. Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men Cancer Causes Control 2010 21 387 391 )| false
• Search Google Scholar

Berwick, M., Armstrong, B. K., Ben-Porat, L., et al.: Sun exposure and mortality from melanoma. J. Natl. Cancer Inst., 2005, 97, 195–199.

Ben-Porat L. , 'Sun exposure and mortality from melanoma ' (2005 ) 97 J. Natl. Cancer Inst. : 195 -199 .

Ben-Porat L. Sun exposure and mortality from melanoma J. Natl. Cancer Inst. 2005 97 195 199 )| false
• Search Google Scholar

Nurnberg, B., Graber, S., Gartner, B., et al.: Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients. Anticancer Res., 2009, 29, 3669–3674.

Gartner B. , 'Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients ' (2009 ) 29 Anticancer Res. : 3669 -3674 .

Gartner B. Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients Anticancer Res. 2009 29 3669 3674 )| false
• Search Google Scholar

Newton-Bishop, J. A., Beswick, S., Randerson-Moor, J., et al.: Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J. Clin. Oncol., 2009, 27, 5439–5444.

Randerson-Moor J. , 'Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma ' (2009 ) 27 J. Clin. Oncol. : 5439 -5444 .

Randerson-Moor J. Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma J. Clin. Oncol. 2009 27 5439 5444 )| false
• Search Google Scholar

Millen, A. E., Tucker, M. A., Hartge, P., et al.: Diet and melanoma in a case-control study. Cancer Epidemiol.; Biomarkers Prev., 2004, 13, 1042–1051.

Hartge P. , 'Diet and melanoma in a case-control study ' (2004 ) 13 Cancer Epidemiol.; Biomarkers Prev. : 1042 -1051 .

Hartge P. Diet and melanoma in a case-control study Cancer Epidemiol.; Biomarkers Prev. 2004 13 1042 1051 )| false
• Search Google Scholar

Holick, M. F.: Photobiology of vitamin D. In: Vitamin D. Second edition. Eds: Feldman, D., et al. Elsevier, Burlington, MA., 2005, Vol. I, 37–46.

Holick M. F. , '', in Vitamin D. Vol. I , (2005 ) -.

Holick M. F. Vitamin D. Vol. I 2005 )| false

Terushkin, V., Bender, A., Psaty, E. L., et al.: Estimated equivalency of vitamin D production from natural sun exposure versus oral vitamin D supplementation across seasons at two US latitudes. J. Am. Acad. Dermatol., 2010, 62 (6), 929.e1–9.

Psaty E. L. , 'Estimated equivalency of vitamin D production from natural sun exposure versus oral vitamin D supplementation across seasons at two US latitudes ' (2010 ) 62 J. Am. Acad. Dermatol. : 929.e1 -9 .

Psaty E. L. Estimated equivalency of vitamin D production from natural sun exposure versus oral vitamin D supplementation across seasons at two US latitudes J. Am. Acad. Dermatol. 2010 62 929.e1 9 )| false
• Search Google Scholar

Wolpowitz, D., Gilchrest, B. A.: The vitamin D questions: how much do you need and how should you get it? J. Am. Acad. Dermatol., 2006, 54, 301–317.

Gilchrest B. A. , 'The vitamin D questions: how much do you need and how should you get it? ' (2006 ) 54 J. Am. Acad. Dermatol. : 301 -317 .

Gilchrest B. A. The vitamin D questions: how much do you need and how should you get it? J. Am. Acad. Dermatol. 2006 54 301 317 )| false
• Search Google Scholar

Bakos, J., Miko, P.: Vitamin D forming effectiveness of ultraviolet radiation from sunlight in different months in Budapest, Hungary. [A nap ultraibolya sugárzásának D-vitamin termelő hatékonysága az év különböző hónapjaiban Magyarországon.] Orv. Hetil., 2007, 148, 319–325. [Hungarian]

Miko P. , 'Vitamin D forming effectiveness of ultraviolet radiation from sunlight in different months in Budapest, Hungary. [A nap ultraibolya sugárzásának D-vitamin termelő hatékonysága az év különböző hónapjaiban Magyarországon.] ' (2007 ) 148 Orv. Hetil. : 319 -325 .

Miko P. Vitamin D forming effectiveness of ultraviolet radiation from sunlight in different months in Budapest, Hungary. [A nap ultraibolya sugárzásának D-vitamin termelő hatékonysága az év különböző hónapjaiban Magyarországon.] Orv. Hetil. 2007 148 319 325 )| false
• Search Google Scholar

Yoshizawa, T., Handa, Y., Uematsu, Y., et al.: Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet., 1997, 16, 391–396.

Uematsu Y. , 'Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning ' (1997 ) 16 Nat. Genet. : 391 -396 .

Uematsu Y. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning Nat. Genet. 1997 16 391 396 )| false
• Search Google Scholar

Dawson-Hughes, B., Heaney, R. P., Holick, M. F., et al.: Estimates of optimal vitamin D status. Osteoporos. Int., 2005, 16, 713–716.

Holick M. F. , 'Estimates of optimal vitamin D status ' (2005 ) 16 Osteoporos. Int. : 713 -716 .

Holick M. F. Estimates of optimal vitamin D status Osteoporos. Int. 2005 16 713 716 )| false
• Search Google Scholar

Adami, S., Isaia, G., Luisetto, G., et al.: Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study. J. Bone Miner. Res., 2006, 21, 1565–1570.

Luisetto G. , 'Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study ' (2006 ) 21 J. Bone Miner. Res. : 1565 -1570 .

Luisetto G. Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study J. Bone Miner. Res. 2006 21 1565 1570 )| false
• Search Google Scholar

Sammons, J., Ahmed, N., El-Sheemy, M., et al.: The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D(3). Stem Cells Dev., 2004, 13, 273–280.

El-Sheemy M. , 'The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D(3) ' (2004 ) 13 Stem Cells Dev. : 273 -280 .

El-Sheemy M. The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D(3) Stem Cells Dev. 2004 13 273 280 )| false
• Search Google Scholar

Duque, G., Macoritto, M., Kremer, R.: 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice ( SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2). Exp. Gerontol., 2004, 39, 333–338.

Kremer R. , '1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice ( SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2) ' (2004 ) 39 Exp. Gerontol. : 333 -338 .

Kremer R. 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice ( SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2) Exp. Gerontol. 2004 39 333 338 )| false
• Search Google Scholar

Gardiner, E. M., Baldock, P. A., Thomas, G. P., et al.: Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage. FASEB J., 2000, 14, 1908–1916.

Thomas G. P. , 'Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage ' (2000 ) 14 FASEB J. : 1908 -1916 .

Thomas G. P. Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage FASEB J. 2000 14 1908 1916 )| false
• Search Google Scholar

Cvengros, V.: Vitamin D and rachitis. Cesk. Pediatr., 1976, 31, 638–640.

Cvengros V. , 'Vitamin D and rachitis ' (1976 ) 31 Cesk. Pediatr. : 638 -640 .

Cvengros V. Vitamin D and rachitis Cesk. Pediatr. 1976 31 638 640 )| false
• Search Google Scholar

Bischoff-Ferrari, H. A., Orav, E. J., Dawson-Hughes, B.: Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch. Intern. Med., 2006, 166, 424–430.

Dawson-Hughes B. , 'Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial ' (2006 ) 166 Arch. Intern. Med. : 424 -430 .

Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial Arch. Intern. Med. 2006 166 424 430 )| false
• Search Google Scholar

Cantorna, M. T.: Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc. Soc. Exp. Biol. Med., 2000, 223, 230–233.

Cantorna M. T. , 'Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? ' (2000 ) 223 Proc. Soc. Exp. Biol. Med. : 230 -233 .

Cantorna M. T. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc. Soc. Exp. Biol. Med. 2000 223 230 233 )| false
• Search Google Scholar

Brown, S. J.: The role of vitamin D in multiple sclerosis. Ann. Pharmacother., 2006, 40, 1158–1161.

Brown S. J. , 'The role of vitamin D in multiple sclerosis ' (2006 ) 40 Ann. Pharmacother. : 1158 -1161 .

Brown S. J. The role of vitamin D in multiple sclerosis Ann. Pharmacother. 2006 40 1158 1161 )| false
• Search Google Scholar

Adorini, L.: Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Annals of the New York Academy of Sciences, 2003, 987, 258–261.

Adorini L. , 'Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes ' (2003 ) 987 Annals of the New York Academy of Sciences : 258 -261 .

Adorini L. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes Annals of the New York Academy of Sciences 2003 987 258 261 )| false
• Search Google Scholar

Munger, K. L., Zhang, S. M., O’Reilly, E., et al.: Vitamin D intake and incidence of multiple sclerosis. Neurology, 2004, 62, 60–65.

O’Reilly E. , 'Vitamin D intake and incidence of multiple sclerosis ' (2004 ) 62 Neurology : 60 -65 .

O’Reilly E. Vitamin D intake and incidence of multiple sclerosis Neurology 2004 62 60 65 )| false
• Search Google Scholar

Munger, K. L., Levin, L. I., Hollis, B. W., et al.: Serum 25-hy-droxyvitamin D levels and risk of multiple sclerosis. JAMA, 2006, 296, 2832–2838.

Hollis B. W. , 'Serum 25-hy-droxyvitamin D levels and risk of multiple sclerosis ' (2006 ) 296 JAMA : 2832 -2838 .

Hollis B. W. Serum 25-hy-droxyvitamin D levels and risk of multiple sclerosis JAMA 2006 296 2832 2838 )| false
• Search Google Scholar

Embry, A. F., Snowdon, L. R., Vieth, R.: Vitamin D and seasonal fuctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann. Neurol., 2000, 48, 271–272.

Vieth R. , 'Vitamin D and seasonal fuctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis ' (2000 ) 48 Ann. Neurol. : 271 -272 .

Vieth R. Vitamin D and seasonal fuctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis Ann. Neurol. 2000 48 271 272 )| false
• Search Google Scholar

Cutolo, M.: Vitamin D and autoimmune rheumatic diseases. Rheumatology (Oxford), 2009, 48, 210–212.

Cutolo M. , 'Vitamin D and autoimmune rheumatic diseases ' (2009 ) 48 Rheumatology (Oxford) : 210 -212 .

Cutolo M. Vitamin D and autoimmune rheumatic diseases Rheumatology (Oxford) 2009 48 210 212 )| false
• Search Google Scholar

Dusso, A. S., Brown, A. J., Slatopolsky, E.: Vitamin D. Am. J. Physiol. Renal. Physiol., 2005, 289, F8–28.

Slatopolsky E. , 'Vitamin D ' (2005 ) 289 Am. J. Physiol. Renal. Physiol. : F8 -28 .

Slatopolsky E. Vitamin D Am. J. Physiol. Renal. Physiol. 2005 289 F8 28 )| false
• Search Google Scholar

Nguyen, T. M., Lieberherr, M., Fritsch, J., et al.: The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin f-broblasts bearing vitamin D receptor mutations. J. Biol. Chem., 2004, 279, 7591–7597.

Fritsch J. , 'The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin f-broblasts bearing vitamin D receptor mutations ' (2004 ) 279 J. Biol. Chem. : 7591 -7597 .

Fritsch J. The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin f-broblasts bearing vitamin D receptor mutations J. Biol. Chem. 2004 279 7591 7597 )| false
• Search Google Scholar

Monkawa, T., Yoshida, T., Hayashi, M., et al.: Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages. Kidney International, 2000, 58, 559–568.

Hayashi M. , 'Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages ' (2000 ) 58 Kidney International : 559 -568 .

Hayashi M. Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages Kidney International 2000 58 559 568 )| false
• Search Google Scholar

Berer, A., Stockl, J., Majdic, O., et al.: 1,25-dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp. Hematol., 2000, 28, 575–583.

Majdic O. , '1,25-dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro ' (2000 ) 28 Exp. Hematol. : 575 -583 .

Majdic O. 1,25-dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro Exp. Hematol. 2000 28 575 583 )| false
• Search Google Scholar

Griffin, M. D., Lutz, W. H., Phan, V. A., et al.: Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem. Biophys. Res. Commun., 2000, 270, 701– 708.

Phan V. A. , 'Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs ' (2000 ) 270 Biochem. Biophys. Res. Commun. : 701 -708 .

Phan V. A. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs Biochem. Biophys. Res. Commun. 2000 270 701 708 )| false
• Search Google Scholar

Urry, Z., Xystrakis, E., Richards, D. F., et al.: Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihy-droxyvitamin D3 abrogates regulatory function. J. Clin. Invest., 2009, 119, 387–398.

Richards D. F. , 'Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihy-droxyvitamin D3 abrogates regulatory function ' (2009 ) 119 J. Clin. Invest. : 387 -398 .

Richards D. F. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihy-droxyvitamin D3 abrogates regulatory function J. Clin. Invest. 2009 119 387 398 )| false
• Search Google Scholar

Penna, G., Roncari, A., Amuchastegui, S., et al.: Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihy-droxyvitamin D3. Blood, 2005, 106, 3490–3497.

Amuchastegui S. , 'Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihy-droxyvitamin D3 ' (2005 ) 106 Blood : 3490 -3497 .

Amuchastegui S. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihy-droxyvitamin D3 Blood 2005 106 3490 3497 )| false
• Search Google Scholar

Barrat, F. J., Cua, D. J., Boonstra, A., et al.: In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med., 2002, 195, 603–616.

Boonstra A. , 'In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines ' (2002 ) 195 J. Exp. Med. : 603 -616 .

Boonstra A. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines J. Exp. Med. 2002 195 603 616 )| false
• Search Google Scholar

Provvedini, D. M., Tsoukas, C. D., Deftos, L. J., et al.: 1 alpha,25-dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. J. Immunol., 1986, 136, 2734–2740.

Deftos L. J. , '1 alpha,25-dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production ' (1986 ) 136 J. Immunol. : 2734 -2740 .

Deftos L. J. 1 alpha,25-dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production J. Immunol. 1986 136 2734 2740 )| false
• Search Google Scholar

Chen, S., Sims, G. P., Chen, X. X., et al.: Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol., 2007, 179, 1634–1647.

Chen X. X. , 'Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation ' (2007 ) 179 J. Immunol. : 1634 -1647 .

Chen X. X. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation J. Immunol. 2007 179 1634 1647 )| false
• Search Google Scholar

Helming, L., Bose, J., Ehrchen, J., et al.: 1alpha,25-dihydroxyvi-tamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood, 2005, 106, 4351–4358.

Ehrchen J. , '1alpha,25-dihydroxyvi-tamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation ' (2005 ) 106 Blood : 4351 -4358 .

Ehrchen J. 1alpha,25-dihydroxyvi-tamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation Blood 2005 106 4351 4358 )| false
• Search Google Scholar

Van Etten, E., Branisteanu, D. D., Verstuyf, A., et al.: Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants. Transplantation, 2000, 69, 1932–1942.

Verstuyf A. , 'Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants ' (2000 ) 69 Transplantation : 1932 -1942 .

Verstuyf A. Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants Transplantation 2000 69 1932 1942 )| false
• Search Google Scholar

Kankova, M., Luini, W., Pedrazzoni, M., et al.: Impairment of cytokine production in mice fed a vitamin D3-deficient diet. Immunology, 1991, 73, 466–471.

Pedrazzoni M. , 'Impairment of cytokine production in mice fed a vitamin D3-deficient diet ' (1991 ) 73 Immunology : 466 -471 .

Pedrazzoni M. Impairment of cytokine production in mice fed a vitamin D3-deficient diet Immunology 1991 73 466 471 )| false
• Search Google Scholar

Bikle, D. D.: What is new in vitamin D: 2006–2007. Curr. Opin. Rheumatol., 2007, 19, 383–388.

Bikle D. D. , 'What is new in vitamin D: 2006–2007 ' (2007 ) 19 Curr. Opin. Rheumatol. : 383 -388 .

Bikle D. D. What is new in vitamin D: 2006–2007 Curr. Opin. Rheumatol. 2007 19 383 388 )| false
• Search Google Scholar

Ritterhouse, L. L., Crowe, S. R., Niewold, T. B., et al.: Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann. Rheum. Dis., 2011, 70, 1569–1574.

Niewold T. B. , 'Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus ' (2011 ) 70 Ann. Rheum. Dis. : 1569 -1574 .

Niewold T. B. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus Ann. Rheum. Dis. 2011 70 1569 1574 )| false
• Search Google Scholar

Lemire, J. M., Archer, D. C.: 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Invest., 1991, 87, 1103–1107.

Archer D. C. , '1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis ' (1991 ) 87 J. Clin. Invest. : 1103 -1107 .

Archer D. C. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis J. Clin. Invest. 1991 87 1103 1107 )| false
• Search Google Scholar

Abe, J., Nakamura, K., Takita Y., et al.: Prevention of immuno-logical disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin D3. J. Nutr. Sci. Vitaminol. (Tokyo), 1990, 36, 21–31.

Takita Y. , 'Prevention of immuno-logical disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin D3 ' (1990 ) 36 J. Nutr. Sci. Vitaminol. (Tokyo) : 21 -31 .

Takita Y. Prevention of immuno-logical disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin D3 J. Nutr. Sci. Vitaminol. (Tokyo) 1990 36 21 31 )| false
• Search Google Scholar

Vaisberg, M. W., Kaneno, R., Franco, M. F., et al.: Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZBxW) mice. J. Clin. Lab. Anal., 2000, 14, 91–96.

Franco M. F. , 'Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZBxW) mice ' (2000 ) 14 J. Clin. Lab. Anal. : 91 -96 .

Franco M. F. Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZBxW) mice J. Clin. Lab. Anal. 2000 14 91 96 )| false
• Search Google Scholar

Tsuji, M., Fujii, K., Nakano, T., et al.: 1 alpha-hydroxyvitamin D3 inhibits type II collagen-induced arthritis in rats. FEBS Lett., 1994, 337, 248–250.

Nakano T. , '1 alpha-hydroxyvitamin D3 inhibits type II collagen-induced arthritis in rats ' (1994 ) 337 FEBS Lett. : 248 -250 .

Nakano T. 1 alpha-hydroxyvitamin D3 inhibits type II collagen-induced arthritis in rats FEBS Lett. 1994 337 248 250 )| false
• Search Google Scholar

Cantorna, M. T., Hayes, C. E., DeLuca, H. F.: 1,25-dihydroxy-cholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J. Nutr., 1998, 128, 68–72.

DeLuca H. F. , '1,25-dihydroxy-cholecalciferol inhibits the progression of arthritis in murine models of human arthritis ' (1998 ) 128 J. Nutr. : 68 -72 .

DeLuca H. F. 1,25-dihydroxy-cholecalciferol inhibits the progression of arthritis in murine models of human arthritis J. Nutr. 1998 128 68 72 )| false
• Search Google Scholar

Zold, E., Szodoray, P., Kappelmayer, J., et al.: Impaired regulatory T-cell homeostasis due to vitamin D deficiency in undifferentiated connective tissue disease. Scand. J. Rheumatol., 2010, 39, 490–497.

Kappelmayer J. , 'Impaired regulatory T-cell homeostasis due to vitamin D deficiency in undifferentiated connective tissue disease ' (2010 ) 39 Scand. J. Rheumatol. : 490 -497 .

Kappelmayer J. Impaired regulatory T-cell homeostasis due to vitamin D deficiency in undifferentiated connective tissue disease Scand. J. Rheumatol. 2010 39 490 497 )| false
• Search Google Scholar

Zold, E., Szodoray, P., Nakken, B., et al.: Alfa-calcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease. Autoimmun. Rev., 2011, 10, 155–162.

Nakken B. , 'Alfa-calcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease ' (2011 ) 10 Autoimmun. Rev. : 155 -162 .

Nakken B. Alfa-calcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease Autoimmun. Rev. 2011 10 155 162 )| false
• Search Google Scholar

Littorin, B., Blom, P., Scholin, A., et al.: Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia, 2006, 49, 2847–2852.

Scholin A. , 'Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS) ' (2006 ) 49 Diabetologia : 2847 -2852 .

Scholin A. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS) Diabetologia 2006 49 2847 2852 )| false
• Search Google Scholar

Chen, S., Glenn, D. J., Ni, W., et al.: Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension, 2008, 52, 1106–1112.

Ni W. , 'Expression of the vitamin D receptor is increased in the hypertrophic heart ' (2008 ) 52 Hypertension : 1106 -1112 .

Ni W. Expression of the vitamin D receptor is increased in the hypertrophic heart Hypertension 2008 52 1106 1112 )| false
• Search Google Scholar

Sellés, J., Bellido, T., Boland, R.: Modulation of calcium uptake in cultured cardiac muscle cells by 1,25-dihydroxyvitamin D3. J. Mol. Cell. Cardiol., 1994, 26, p. 1593–1599.

Boland R. , 'Modulation of calcium uptake in cultured cardiac muscle cells by 1,25-dihydroxyvitamin D3 ' (1994 ) 26 J. Mol. Cell. Cardiol. : p. 1593 -1599 .

Boland R. Modulation of calcium uptake in cultured cardiac muscle cells by 1,25-dihydroxyvitamin D3 J. Mol. Cell. Cardiol. 1994 26 p. 1593 1599 )| false
• Search Google Scholar

Szeto, F. L., Sun, J., Kong, J., et al.: Involvement of the vitamin D receptor in the regulation of NF-kappaB activity in fibro-blasts. J. Steroid Biochem. Mol. Biol., 2007, 103, 563–566.

Kong J. , 'Involvement of the vitamin D receptor in the regulation of NF-kappaB activity in fibro-blasts ' (2007 ) 103 J. Steroid Biochem. Mol. Biol. : 563 -566 .

Kong J. Involvement of the vitamin D receptor in the regulation of NF-kappaB activity in fibro-blasts J. Steroid Biochem. Mol. Biol. 2007 103 563 566 )| false
• Search Google Scholar

Zittermann, A.: Vitamin D and disease prevention with special reference to cardiovascular disease. Prog. Biophys. Mol. Biol., 2006, 92, 39–48.

Zittermann A. , 'Vitamin D and disease prevention with special reference to cardiovascular disease ' (2006 ) 92 Prog. Biophys. Mol. Biol. : 39 -48 .

Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease Prog. Biophys. Mol. Biol. 2006 92 39 48 )| false
• Search Google Scholar

Rahman, A., Hershey, S., Ahmed, S., et al.: Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J. Steroid Biochem. Mol. Biol., 2007, 103, 416–419.

Ahmed S. , 'Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice ' (2007 ) 103 J. Steroid Biochem. Mol. Biol. : 416 -419 .

Ahmed S. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice J. Steroid Biochem. Mol. Biol. 2007 103 416 419 )| false
• Search Google Scholar

Li, Y. Y., Feng, Y. Q., Kadokami, T., et al.: Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc. Natl. Acad. Sci. USA, 2000, 97, 12746–12751.

Kadokami T. , 'Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy ' (2000 ) 97 Proc. Natl. Acad. Sci. USA : 12746 -12751 .

Kadokami T. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy Proc. Natl. Acad. Sci. USA 2000 97 12746 12751 )| false
• Search Google Scholar

Mancuso, P., Rahman, A., Hershey, S. D., et al.: 1,25-dihydroxy-vitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin. J. Cardiovasc. Pharmacol., 2008, 51, 559–564.

Hershey S. D. , '1,25-dihydroxy-vitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin ' (2008 ) 51 J. Cardiovasc. Pharmacol. : 559 -564 .

Hershey S. D. 1,25-dihydroxy-vitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin J. Cardiovasc. Pharmacol. 2008 51 559 564 )| false
• Search Google Scholar

Simpson, R. U., Hershey, S. H., Nibbelink, K. A.: Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J. Steroid Biochem. Mol. Biol., 2007, 103, 521–524.

Nibbelink K. A. , 'Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse ' (2007 ) 103 J. Steroid Biochem. Mol. Biol. : 521 -524 .

Nibbelink K. A. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse J. Steroid Biochem. Mol. Biol. 2007 103 521 524 )| false
• Search Google Scholar

Olgun, H., Ceviz, N., Ozkan, B.: A case of dilated cardiomyopa-thy due to nutritional vitamin D deficiency rickets. Turkish Journal of Pediatrics, 2003, 45, 152–154.

Ozkan B. , 'A case of dilated cardiomyopa-thy due to nutritional vitamin D deficiency rickets ' (2003 ) 45 Turkish Journal of Pediatrics : 152 -154 .

Ozkan B. A case of dilated cardiomyopa-thy due to nutritional vitamin D deficiency rickets Turkish Journal of Pediatrics 2003 45 152 154 )| false
• Search Google Scholar

Carlton-Conway, D., Tulloh, R., Wood, L., et al.: Vitamin D deficiency and cardiac failure in infancy. J. R. Soc. Med., 2004, 97, 238–239.

Wood L. , 'Vitamin D deficiency and cardiac failure in infancy ' (2004 ) 97 J. R. Soc. Med. : 238 -239 .

Wood L. Vitamin D deficiency and cardiac failure in infancy J. R. Soc. Med. 2004 97 238 239 )| false
• Search Google Scholar

Brunvand, L., Haga, P., Tangsrud, S. E., et al.: Congestive heart failure caused by vitamin D deficiency? Acta Paediatr., 1995, 84, 106–108.

Tangsrud S. E. , 'Congestive heart failure caused by vitamin D deficiency? ' (1995 ) 84 Acta Paediatr. : 106 -108 .

Tangsrud S. E. Congestive heart failure caused by vitamin D deficiency? Acta Paediatr. 1995 84 106 108 )| false
• Search Google Scholar

Maiya, S., Sullivan, I., Allgrove, J., et al.: Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. [See comment.] Heart, 2008, 94, 581–584.

Allgrove J. , 'Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. [See comment.] ' (2008 ) 94 Heart : 581 -584 .

Allgrove J. Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. [See comment.] Heart 2008 94 581 584 )| false
• Search Google Scholar

Kristal-Boneh, E., Froom, P., Harari, G., et al.: Association of calcitriol and blood pressure in normotensive men. Hypertension, 1997, 30, 1289–1294.

Harari G. , 'Association of calcitriol and blood pressure in normotensive men ' (1997 ) 30 Hypertension : 1289 -1294 .

Harari G. Association of calcitriol and blood pressure in normotensive men Hypertension 1997 30 1289 1294 )| false
• Search Google Scholar

Scragg, R., Sowers, M., Bell, C.: Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am. J. Hypertens., 2007, 20, 713–719.

Bell C. , 'Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey ' (2007 ) 20 Am. J. Hypertens. : 713 -719 .

Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey Am. J. Hypertens. 2007 20 713 719 )| false
• Search Google Scholar

Zhou, C., Lu, F., Cao, K., et al.: Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. [See comment.] Kidney International, 2008, 74, 170–179.

Cao K. , 'Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. [See comment.] ' (2008 ) 74 Kidney International : 170 -179 .

Cao K. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. [See comment.] Kidney International 2008 74 170 179 )| false
• Search Google Scholar

Kim, D. H., Sabour, S., Sagar, U. N., et al.: Prevalence of hypo-vitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am. J. Cardiol., 2008, 102, 1540–1544.

Sagar U. N. , 'Prevalence of hypo-vitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004) ' (2008 ) 102 Am. J. Cardiol. : 1540 -1544 .

Sagar U. N. Prevalence of hypo-vitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004) Am. J. Cardiol. 2008 102 1540 1544 )| false
• Search Google Scholar

Xiang, W., Kong, J., Chen, S., et al.: Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am. J. Physiol. Endocrinol. Metab., 2005, 288, E125–132.

Chen S. , 'Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems ' (2005 ) 288 Am. J. Physiol. Endocrinol. Metab. : E125 -132 .

Chen S. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems Am. J. Physiol. Endocrinol. Metab. 2005 288 E125 132 )| false
• Search Google Scholar

Park, C. W., Oh, Y. S., Shin, Y. S., et al.: Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am. J. Kidney Dis., 1999, 33, 73–81.

Shin Y. S. , 'Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism ' (1999 ) 33 Am. J. Kidney Dis. : 73 -81 .

Shin Y. S. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism Am. J. Kidney Dis. 1999 33 73 81 )| false
• Search Google Scholar

Wong, M. S., Delansorne, R., Man, R. Y., et al.: Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am. J. Physiol. Heart Circ. Physiol., 2008, 295, H289–296.

Man R. Y. , 'Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat ' (2008 ) 295 Am. J. Physiol. Heart Circ. Physiol. : H289 -296 .

Man R. Y. Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat Am. J. Physiol. Heart Circ. Physiol. 2008 295 H289 296 )| false
• Search Google Scholar

Zittermann, A., Schleithoff, S. S., Koerfer, R.: Vitamin D and vascular calcification. Curr. Opin. Lipidol., 2007, 18, 41–46.

Koerfer R. , 'Vitamin D and vascular calcification ' (2007 ) 18 Curr. Opin. Lipidol. : 41 -46 .

Koerfer R. Vitamin D and vascular calcification Curr. Opin. Lipidol. 2007 18 41 46 )| false
• Search Google Scholar

Talmor, Y., Bernheim, J., Klein, O., et al.: Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro. Eur. J. Clin. Invest., 2008, 38, 548–554.

Klein O. , 'Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro ' (2008 ) 38 Eur. J. Clin. Invest. : 548 -554 .

Klein O. Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro Eur. J. Clin. Invest. 2008 38 548 554 )| false
• Search Google Scholar

Watson, K. E., Abrolat, M. L., Malone, L. L., et al.: Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation, 1997, 96, 1755–1760.

Malone L. L. , 'Active serum vitamin D levels are inversely correlated with coronary calcification ' (1997 ) 96 Circulation : 1755 -1760 .

Malone L. L. Active serum vitamin D levels are inversely correlated with coronary calcification Circulation 1997 96 1755 1760 )| false
• Search Google Scholar

Giovannucci, E., Liu, Y., Hollis, B. W., et al.: 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med., 2008, 168, 1174–1180.

Hollis B. W. , '25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study ' (2008 ) 168 Arch. Intern. Med. : 1174 -1180 .

Hollis B. W. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study Arch. Intern. Med. 2008 168 1174 1180 )| false
• Search Google Scholar

Reis, J. P., von Muhlen, D., Miller, E. R. 3rd, et al.: Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics, 2009, 124, e371–379.

Miller E. R. , 'Vitamin D status and cardiometabolic risk factors in the United States adolescent population ' (2009 ) 124 Pediatrics : e371 -379 .

Miller E. R. Vitamin D status and cardiometabolic risk factors in the United States adolescent population Pediatrics 2009 124 e371 379 )| false
• Search Google Scholar

Johnson, M. D., Nader, N. S., Weaver, A. L., et al.: Relationships between 25-hydroxyvitamin D levels and plasma glucose and lipid levels in pediatric outpatients. J. Pediatr., 2010, 156, 444– 449.

Weaver A. L. , 'Relationships between 25-hydroxyvitamin D levels and plasma glucose and lipid levels in pediatric outpatients ' (2010 ) 156 J. Pediatr. : 444 -449 .

Weaver A. L. Relationships between 25-hydroxyvitamin D levels and plasma glucose and lipid levels in pediatric outpatients J. Pediatr. 2010 156 444 449 )| false
• Search Google Scholar

Dahlquist, G., Mustonen, L.: Childhood onset diabetes – time trends and climatological factors. Int. J. Epidemiol., 1994, 23, 1234–1241.

Mustonen L. , 'Childhood onset diabetes – time trends and climatological factors ' (1994 ) 23 Int. J. Epidemiol. : 1234 -1241 .

Mustonen L. Childhood onset diabetes – time trends and climatological factors Int. J. Epidemiol. 1994 23 1234 1241 )| false
• Search Google Scholar

Moltchanova, E. V., Schreier, N., Lammi, N., et al.: Seasonal variation of diagnosis of type 1 diabetes mellitus in children worldwide. Diabet. Med., 2009, 26, 673–678.

Lammi N. , 'Seasonal variation of diagnosis of type 1 diabetes mellitus in children worldwide ' (2009 ) 26 Diabet. Med. : 673 -678 .

Lammi N. Seasonal variation of diagnosis of type 1 diabetes mellitus in children worldwide Diabet. Med. 2009 26 673 678 )| false
• Search Google Scholar

Norman, A. W., Frankel, J. B., Heldt, A. M., et al.: Vitamin D deficiency inhibits pancreatic secretion of insulin. Science, 1980, 209, 823–825.

Heldt A. M. , 'Vitamin D deficiency inhibits pancreatic secretion of insulin ' (1980 ) 209 Science : 823 -825 .

Heldt A. M. Vitamin D deficiency inhibits pancreatic secretion of insulin Science 1980 209 823 825 )| false
• Search Google Scholar

Giulietti, A., Gysemans, C., Stoffels, K., et al.: Vitamin D def-ciency in early life accelerates type 1 diabetes in non-obese diabetic mice. Diabetologia, 2004, 47, 451–462.

Stoffels K. , 'Vitamin D def-ciency in early life accelerates type 1 diabetes in non-obese diabetic mice ' (2004 ) 47 Diabetologia : 451 -462 .

Stoffels K. Vitamin D def-ciency in early life accelerates type 1 diabetes in non-obese diabetic mice Diabetologia 2004 47 451 462 )| false
• Search Google Scholar

Stene, L. C., Ulriksen, J., Magnus, P., et al.: Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring. Diabetologia, 2000, 43, 1093–1098.

Magnus P. , 'Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring ' (2000 ) 43 Diabetologia : 1093 -1098 .

Magnus P. Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring Diabetologia 2000 43 1093 1098 )| false
• Search Google Scholar

Stene, L. C., Joner, G.: Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am. J. Clin. Nutr., 2003, 78, 1128–1134.

Joner G. , 'Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study ' (2003 ) 78 Am. J. Clin. Nutr. : 1128 -1134 .

Joner G. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study Am. J. Clin. Nutr. 2003 78 1128 1134 )| false
• Search Google Scholar

The EURODIAB Sub-study 2 Study Group: Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. Diabetologia, 1999, 42, 51–54.

'Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus ' (1999 ) 42 Diabetologia : 51 -54 .

Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus Diabetologia 1999 42 51 54 )| false
• Search Google Scholar

Hypponen, E., Laara, E., Reunanen, A., et al.: Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet, 2001, 358, 1500–1503.

Reunanen A. , 'Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study ' (2001 ) 358 Lancet : 1500 -1503 .

Reunanen A. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study Lancet 2001 358 1500 1503 )| false
• Search Google Scholar

Wareham, N. J., Byrne, C. D., Carr, C., et al.: Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism, 1997, 46, 1171–1177.

Carr C. , 'Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality ' (1997 ) 46 Metabolism : 1171 -1177 .

Carr C. Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality Metabolism 1997 46 1171 1177 )| false
• Search Google Scholar

Feldman, D., Pike, J. W., Adams, J. S.: Vitamin D. 3rd ed., Academic Press, Amsterdam, Boston, 2011.

Adams J. S. , '', in Vitamin D , (2011 ) -.

Adams J. S. Vitamin D 2011 )| false

Parikh, S. J., Edelman, M., Uwaifo, G. I., et al.: The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J. Clin. Endocrinol. Metab., 2004, 89, 1196–1199.

Uwaifo G. I. , 'The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults ' (2004 ) 89 J. Clin. Endocrinol. Metab. : 1196 -1199 .

Uwaifo G. I. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults J. Clin. Endocrinol. Metab. 2004 89 1196 1199 )| false
• Search Google Scholar

Wortsman, J., Matsuoka, L. Y., Chen, T. C., et al.: Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr., 2000, 72, 690–693.

Chen T. C. , 'Decreased bioavailability of vitamin D in obesity ' (2000 ) 72 Am. J. Clin. Nutr. : 690 -693 .

Chen T. C. Decreased bioavailability of vitamin D in obesity Am. J. Clin. Nutr. 2000 72 690 693 )| false
• Search Google Scholar

Jorde, R., Sneve, M., Emaus, N., et al.: Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromso study. Eur. J. Nutr., 2010, 49, 401–407.

Emaus N. , 'Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromso study ' (2010 ) 49 Eur. J. Nutr. : 401 -407 .

Emaus N. Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromso study Eur. J. Nutr. 2010 49 401 407 )| false
• Search Google Scholar

Arunabh, S., Pollack, S., Yeh, J., et al.: Body fat content and 25-hydroxyvitamin D levels in healthy women. J. Clin. Endocrinol. Metab., 2003, 88, 157–161.

Yeh J. , 'Body fat content and 25-hydroxyvitamin D levels in healthy women ' (2003 ) 88 J. Clin. Endocrinol. Metab. : 157 -161 .

Yeh J. Body fat content and 25-hydroxyvitamin D levels in healthy women J. Clin. Endocrinol. Metab. 2003 88 157 161 )| false
• Search Google Scholar

Narvaez, C. J., Matthews, D., Broun, E., et al.: Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling pro-tein-1 in white adipose tissue. Endocrinology, 2009, 150, 651– 661.

Broun E. , 'Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling pro-tein-1 in white adipose tissue ' (2009 ) 150 Endocrinology : 651 -661 .

Broun E. Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling pro-tein-1 in white adipose tissue Endocrinology 2009 150 651 661 )| false
• Search Google Scholar

Wong, K. E., Szeto, F. L., Zhang, W., et al.: Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am. J. Physiol. Endocrinol. Metab., 2009, 296, E820–828.

Zhang W. , 'Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins ' (2009 ) 296 Am. J. Physiol. Endocrinol. Metab. : E820 -828 .

Zhang W. Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins Am. J. Physiol. Endocrinol. Metab. 2009 296 E820 828 )| false
• Search Google Scholar

Eyles, D. W., Smith, S., Kinobe, R., et al.: Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J. Chem. Neuroanat., 2005, 29, 21–30.

Kinobe R. , 'Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain ' (2005 ) 29 J. Chem. Neuroanat. : 21 -30 .

Kinobe R. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain J. Chem. Neuroanat. 2005 29 21 30 )| false
• Search Google Scholar

Harms, L. R., Burne, T. H., Eyles, D. W., et al.: Vitamin D and the brain. Best Pract. Res. Clin. Endocrinol. Metab., 2011, 25, 657–669.

Eyles D. W. , 'Vitamin D and the brain ' (2011 ) 25 Best Pract. Res. Clin. Endocrinol. Metab. : 657 -669 .

Eyles D. W. Vitamin D and the brain Best Pract. Res. Clin. Endocrinol. Metab. 2011 25 657 669 )| false
• Search Google Scholar

McGrath, J. J., Eyles, D. W., Pedersen, C. B., et al.: Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Arch. Gen. Psychiatry, 2010, 67, 889–894.

Pedersen C. B. , 'Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study ' (2010 ) 67 Arch. Gen. Psychiatry : 889 -894 .

Pedersen C. B. Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study Arch. Gen. Psychiatry 2010 67 889 894 )| false
• Search Google Scholar

Mowry, E. M., Krupp, L. B., Milazzo, M., et al.: Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann. Neurol., 2010, 67, 618–624.

Milazzo M. , 'Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis ' (2010 ) 67 Ann. Neurol. : 618 -624 .

Milazzo M. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis Ann. Neurol. 2010 67 618 624 )| false
• Search Google Scholar

Correale, J., Ysrraelit, M. C., Gaitan, M. I.: Immunomodula-tory effects of vitamin D in multiple sclerosis. Brain, 2009, 132, 1146–1160.

Gaitan M. I. , 'Immunomodula-tory effects of vitamin D in multiple sclerosis ' (2009 ) 132 Brain : 1146 -1160 .

Gaitan M. I. Immunomodula-tory effects of vitamin D in multiple sclerosis Brain 2009 132 1146 1160 )| false
• Search Google Scholar

Smolders, J., Hupperts, R., Barkhof, F., et al.: Efficacy of vitamin D(3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial. J. Neurol. Sci., 2011, 311, 44–49.

Barkhof F. , 'Efficacy of vitamin D(3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial ' (2011 ) 311 J. Neurol. Sci. : 44 -49 .